Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02454647 | Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients | completed | — | 46 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT01838109 | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | completed | N/A | 174 | Seoul National University HospitalOTHER | 1 | May 27, 2015 |
| clinicaltrials |
| NCT02454673 | Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer | completed | — | 121 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02450032 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer(GC5) | completed | Phase 2 | 12 | Cancer Advances Inc.INDUSTRY | 1 | May 21, 2015 | clinicaltrials |
| NCT01136031 | Paclitaxel and Irinotecan in Advanced Gastric Cancer(TI-2ndAGC) | completed | Phase 1 / Phase 2 | 42 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02216110 | Endoscopic Submucosal Dissection Versus Gastrectomy | completed | — | 500 | Soonchunhyang University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00477711 | A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer(EXTRA) | completed | Phase 2 | 41 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00842491 | Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer | completed | Phase 2 | 45 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT01336062 | Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 19 | Peking UniversityOTHER | 1 | May 19, 2015 | clinicaltrials |
| NCT00718913 | Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer | completed | Phase 2 | 40 | Hellenic Oncology Research GroupOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT02444897 | The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy | completed | Phase 3 | 60 | Keimyung University Dongsan Medical CenterOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT00718354 | Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT(GASTRANOX) | completed | Phase 3 | 740 | Thrombosis Research InstituteOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | May 13, 2015 | clinicaltrials |
| NCT00084617 | Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 1, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT02425930 | The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer | completed | — | 85 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02372747 | Comparison of Delta-Shaped and Billroth II After TLDG(TLDG) | completed | N/A | 78 | The First Hospital of Jilin UniversityOTHER | 0 | Feb 26, 2015 | clinicaltrials |
| NCT00673673 | FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer | completed | Phase 2 | 39 | Yale UniversityOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT02348229 | Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins(ERASAG) | completed | N/A | 149 | The First Hospital of Jilin UniversityOTHER | 0 | Jan 28, 2015 | clinicaltrials |
| NCT01760070 | Comparison of O-type Hybrid Knife and IT Knife in ESD | completed | N/A | 78 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | completed | Phase 2 | 15 | Eli Lilly and CompanyINDUSTRY | 2 | Jan 16, 2015 | clinicaltrials |
| NCT01614522 | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2 | completed | Phase 2 | 24 | ASLAN PharmaceuticalsOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01544413 | Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer | completed | N/A | 112 | National Cancer Center, KoreaOTHER_GOV | 1 | Dec 16, 2014 | clinicaltrials |
| NCT00253370 | Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01497964 | Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy(GASTANA) | completed | Phase 1 / Phase 2 | 16 | SanofiINDUSTRY | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer(DaeMon) | completed | Phase 2 | 39 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | completed | Phase 3 | 584 | Hoffmann-La RocheINDUSTRY | 24 | Nov 5, 2014 | clinicaltrials |
| NCT01138904 | FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) | completed | Phase 2 | 80 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | completed | Phase 2 | 168 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00006389 | Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT01471756 | Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia | completed | Phase 4 | 66 | Mayo ClinicOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT02233712 | Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.(GC3) | completed | Phase 2 | 33 | Cancer Advances Inc.INDUSTRY | 0 | Sep 8, 2014 | clinicaltrials |
| NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Early Phase 1 | 25 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT00678535 | Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer(EXPAND) | completed | Phase 3 | 904 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 25 | Jul 21, 2014 | clinicaltrials |
| NCT00005956 | Biological Therapy in Treating Patients With Advanced Cancer | completed | N/A | 3 | Duke UniversityOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00313599 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | University of California, San FranciscoOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00991952 | Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 26, 2014 | clinicaltrials |
| NCT00183846 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | completed | Phase 1 | 22 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183859 | Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | completed | Phase 1 | 42 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | completed | Phase 2 | 25 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01758965 | Surgicel® Fibrillar for Delayed Bleeding After ESD | completed | N/A | 146 | Soonchunhyang University HospitalOTHER | 1 | May 13, 2014 | clinicaltrials |
| NCT01896310 | New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy | completed | — | 272 | Shandong UniversityOTHER | 1 | May 13, 2014 | clinicaltrials |
| NCT01379482 | Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer | completed | Phase 2 | 18 | Uppsala UniversityOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01444521 | Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer | completed | Phase 2 | 50 | Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | completed | Phase 1 / Phase 2 | 86 | Chinese PLA General HospitalOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT01435525 | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation | completed | — | 369 | AstraZenecaINDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01672333 | Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma(TOX) | completed | Phase 2 | 50 | Milad HospitalOTHER | 1 | Mar 20, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 28, 2015source: clinicaltrials